CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE
DEAD

Serial Number

79338773

Owner

Centre for Commercialization of Regenerative Medicine

Filing Date

Nov 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE Trademark

Serial Number: 79338773

CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE is a trademark filed by Centre for Commercialization of Regenerative Medicine on November 19, 2021. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Centre for Commercialization of Regenerative Medicine (3 trademarks)

661 University Avenue

Entity Type: 54

Trademark Details

Filing Date

November 19, 2021

Registration Date

Not Registered

Goods & Services

Reviewing standards and practices to assure compliance with regulations related to the research, development, manufacture and sale of products in the health care and medical fields and the administration of health care services

Development of pharmaceutical preparations and medicines; pharmaceutical research and development; the research and development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; providing medical and scientific research information in the field of clinical trials; clinical trials; genetic testing for scientific research purposes; genetic engineering; genetic testing for scientific research purposes

Cryopreservation services; custom manufacture of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms

Business planning; providing market intelligence services

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Mar 19, 2026 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 11, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jul 22, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 22, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 16, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 27, 2023 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 21, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 21, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 21, 2023 ABN2
ASSIGNED TO EXAMINER
Jul 19, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2023 NREP
REFUSAL PROCESSED BY IB
Jan 9, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 19, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 19, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 6, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 5, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2022 REPR